NCT07249918 is a NA clinical trial of Re-Timer (light therapy glasses) in Alzheimer's Dementia, sponsored by China Medical University Hospital.

Who is sponsoring NCT07249918?

NCT07249918 is sponsored by China Medical University Hospital.

What drugs are being tested in NCT07249918?

Interventions in NCT07249918: Re-Timer (light therapy glasses).

What condition does NCT07249918 study?

NCT07249918 studies Alzheimer's Dementia, Neuropsychiatric Symptoms Related to Neurodegenerative Disease, Wearable Devices, Caregiver Burden of People With Dementia, Circadian Rhythm.

Is NCT07249918 still recruiting?

NCT07249918 is currently recruiting now. Last updated 11 February 2026.

Last reviewed 2026-02-11 · How we verify

NCT07249918

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility of Wearables in Dementia Care in Rural Taiwan

Recruiting now NA Last updated 11 February 2026

What this trial tests

NA trial testing Re-Timer (light therapy glasses) in Alzheimer's Dementia in 20 participants. Currently enrolling.

Timeline

18 November 2025

Primary endpoint
30 September 2026

31 December 2026

Quick facts

Lead sponsor	China Medical University Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	18 November 2025
Primary completion	30 September 2026
Estimated completion	31 December 2026
Sites	1 location across Taiwan

Drugs / interventions tested

Re-Timer (light therapy glasses)

Conditions studied

Alzheimer's Dementia — all drugs for Alzheimer's Dementia →
Neuropsychiatric Symptoms Related to Neurodegenerative Disease — all drugs for Neuropsychiatric Symptoms Related to Neurodegenerative Disease →
Wearable Devices — all drugs for Wearable Devices →
Caregiver Burden of People With Dementia — all drugs for Caregiver Burden of People With Dementia →

Sponsor

China Medical University Hospital

Who can join

Eligibility, any sex, with Alzheimer's Dementia or Neuropsychiatric Symptoms Related to Neurodegenerative Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Taiwan is becoming a super-aged society, and more older adults are living with Alzheimer's disease. Many people with Alzheimer's experience behavioral and psychological symptoms, such as agitation, sleep problems, or mood changes. These symptoms often lower their quality of life and increase stress for their family caregivers. This study will test two wearable devices in people with Alzheimer's and their caregivers. One device, called Geneactiv, is a wristwatch that tracks daily activity and sleep. The other device, called Re-Timer, is a light therapy eyewear that may help improve sleep and mood. Researchers will look at how easy the devices are to use, whether participants are willing to wear them for several weeks, and whether the light therapy helps reduce sleep problems or caregiver stress. The study will also compare information from questionnaires with information collected by the devices. The results may help researchers design future studies using wearable tools to better support people living with dementia and their caregivers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Facilitating the measurement and treatment of Behavioral and Psychological Symptoms of Dementia (BPSD) and understanding caregiver burden using wearable devices in Rural Taiwan-Protocol for a dyadic feasibility pilot study.
Guu TW, Li WJ, Lee SH, Hsu CS, et al · · 2026 · PMID 42149841 · DOI 10.1371/journal.pone.0342136

Verify or expand the search:

Other recruiting trials for Alzheimer's Dementia

Currently open trials in the same condition.

NCT06534723 — Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of De · Phase 3 · recruiting

Other China Medical University Hospital trials

Trials by the same sponsor.

NCT07525700 — The Effects of Combining Electronic Picture Books With RPG-Based Gamified Learning on Nursing Students' Motivation and L · NA · not yet recruiting
NCT07463391 — Chinese Classics Recitation Training in Subjective Cognitive Decline · NA · not yet recruiting
NCT07482189 — Effectiveness and Efficiency of an Upper Limb Active-Passive Exoskeleton Robot in Patients With Frozen Shoulder · NA · not yet recruiting
NCT07437144 — Exploring the Effects of Shangshou Daoyin Method on Improving Sleep Quality, Quality of Life, and TCM Constitution in Br · NA · not yet recruiting
NCT07232667 — Digital Technology for Active and Healthy Ageing in Taiwan · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07249918 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by China Medical University Hospital
Last refreshed: 11 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07249918.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing